1
Participants
Start Date
January 12, 2024
Primary Completion Date
June 2, 2024
Study Completion Date
June 2, 2024
ABBV-950
Intramuscular (IM) Injection
BOTOX
Intramuscular (IM) Injection
Placebo for ABBV-950
Intramuscular (IM) Injection
MedStar National Rehabilitation Hospital /ID# 255630, Washington D.C.
University of Missouri Hospital /ID# 255310, Columbia
Rancho Los Amigos National Rehabilitation center /ID# 255335, Downey
North County Neurology Associates /ID# 256333, Carlsbad
Neuro Pain Medical Center /ID# 256036, Fresno
New England Institute for Clinical Research /ID# 255020, Stamford
JEM Research Institute /ID# 258782, Lake Worth
Kansas Institute of Research /ID# 254998, Overland Park
Ut Southwestern Medical Center /Parkland Health and Hospital System /Id# 255328, Dallas
Lead Sponsor
AbbVie
INDUSTRY